Arbutus Biopharma Corp. (ABUS)
4.45
-0.11
(-2.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.475
+0.02
(+0.56%)
After-Hours: 20:00
Arbutus Biopharma Price : 4.45 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.55 | 4.68 | 4.375 | 4.45 | 8.987M |
| Oct 01, 2026 | 4.77 | 4.775 | 4.51 | 4.56 | 16.12M |
| Sep 30, 2026 | 4.675 | 4.95 | 4.675 | 4.78 | 16.88M |
| Sep 29, 2026 | 4.86 | 4.89 | 4.67 | 4.69 | 17.56M |
| Sep 28, 2026 | 4.84 | 4.88 | 4.80 | 4.86 | 11.67M |
| Sep 25, 2026 | 4.89 | 4.93 | 4.84 | 4.85 | 16.88M |
| Sep 24, 2026 | 4.85 | 4.885 | 4.801 | 4.88 | 6.263M |
| Sep 23, 2026 | 5.01 | 5.02 | 4.84 | 4.85 | 10.84M |
| Sep 22, 2026 | 5.02 | 5.05 | 4.995 | 5.01 | 10.49M |
| Sep 21, 2026 | 5.03 | 5.07 | 4.99 | 5.00 | 4.563M |
| Sep 18, 2026 | 5.04 | 5.06 | 4.98 | 5.01 | 6.459M |
| Sep 17, 2026 | 5.10 | 5.10 | 5.04 | 5.07 | 2.715M |
| Sep 16, 2026 | 5.06 | 5.089 | 5.02 | 5.05 | 4.009M |
| Sep 15, 2026 | 5.11 | 5.15 | 5.03 | 5.06 | 4.052M |
| Sep 14, 2026 | 5.12 | 5.16 | 5.095 | 5.13 | 3.803M |
| Sep 11, 2026 | 5.17 | 5.175 | 5.11 | 5.12 | 1.850M |
| Sep 10, 2026 | 5.11 | 5.165 | 5.10 | 5.12 | 2.450M |
| Sep 09, 2026 | 5.16 | 5.23 | 5.125 | 5.17 | 5.507M |
| Sep 08, 2026 | 5.10 | 5.20 | 5.08 | 5.18 | 5.291M |
| Sep 04, 2026 | 5.09 | 5.17 | 5.09 | 5.15 | 5.198M |
| Sep 03, 2026 | 5.11 | 5.154 | 5.095 | 5.12 | 3.227M |
| Sep 02, 2026 | 5.10 | 5.19 | 5.09 | 5.10 | 2.976M |
| Sep 01, 2026 | 5.05 | 5.10 | 5.05 | 5.09 | 2.610M |
| Aug 31, 2026 | 5.05 | 5.105 | 4.992 | 5.08 | 3.562M |
| Aug 28, 2026 | 5.15 | 5.19 | 5.05 | 5.07 | 4.769M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Insmed, Inc. | 111.12 |
| Pfizer Inc. | 27.80 |
| Gossamer Bio, Inc. | 10.71 |
| Legend Biotech Corp. | 18.57 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
Price Related Metrics
| PE Ratio | 5.680 |
| PS Ratio | 4.757 |
| Price to Book Value | 3.399 |
| Earnings Yield | 17.60% |
| Market Cap | 879.47M |
| Operating PE Ratio | 5.863 |
| Normalized PE Ratio | 5.723 |